YBX1 and hepatocellular carcinoma: Conversely, Immune-related GTPase (IRGM) binds directly to YBX1, facilitating its phosphorylation and nuclear localization, which subsequently upregulates Programmed Death-Ligand 1 (PD-L1) expression and promotes the malignant progression of hepatocellular carcinoma [70].